The first effects of the arrival of the European Medicines Agency EMA are already being felt.
The EMA effect is also good news for scientific research. Director Bart Klijsen of IXA VU-VUmc says, “In order to bring research to society, cooperation and participation with companies is indispensable. This requires a mature ecosystem. That is why the arrival of EMA is positive for the Netherlands and for the region. Although not all contacts are directly related to EMA, there is a lot more interest from the medical industry in Amsterdam.”
Read the full Parool article of Herman Stil, Artikel-Parool-Als-EMA-over-de-dam-is…..pdf
Longform.ai BV, a spin-off from the University of Amsterdam (UvA) and based in Amsterdam, has secured €300,000 in funding from Innovatiefonds Noord-Holland. In addition, the company has benefited from extensive mentorship provided by the TTT-AI program, accelerating both its research and commercialization efforts. Longform.ai is building a cutting-edge platform that leverages generative AI to extract […]
NewsImran Avci, from the Department of Physics and Astronomy at Vrije Universiteit Amsterdam, has secured the NOW Demonstrator grant for a project titled SOHO: A New Approach for Ultra-Precise, Fast, and Sensitive Photonic Microchip Measurements. The innovation in this field is expected to lead to breakthroughs in quantum computing, neuromorphic processors, wearable sensors, Lidar systems, […]
NewsWe’re thrilled to share the success of the HvA-wide EXPLORE Workshops, organized by the Venture Centre HvA (part of IXA-HvA). These workshops are designed to ignite entrepreneurial spirit among students, helping them discover their competencies and attitudes. The goal? Equip students to spot opportunities and create value within their fields—whether in business, healthcare, or other […]
News